These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37832344)

  • 21. Evaluation of a bivalent recombinant vaccine candidate targeting norovirus and rotavirus: Antibodies to rotavirus NSP4 exert antidiarrheal effects without virus neutralization.
    Cao H; Wu J; Luan N; Wang Y; Lin K; Liu C
    J Med Virol; 2022 Aug; 94(8):3847-3856. PubMed ID: 35474320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine.
    Lappalainen S; Pastor AR; Malm M; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
    Arch Virol; 2015 Aug; 160(8):2075-8. PubMed ID: 26016444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the efficacy of rotavirus VLP vaccines to a live homologous rotavirus vaccine in a pig model of rotavirus disease.
    El-Attar L; Oliver SL; Mackie A; Charpilienne A; Poncet D; Cohen J; Bridger JC
    Vaccine; 2009 May; 27(24):3201-8. PubMed ID: 19446192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineering and expression of a human rotavirus candidate vaccine in Nicotiana benthamiana.
    Pêra FF; Mutepfa DL; Khan AM; Els JH; Mbewana S; van Dijk AA; Rybicki EP; Hitzeroth II
    Virol J; 2015 Dec; 12():205. PubMed ID: 26626122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of rotavirus NSP4 protein on the immune response and protection of the S
    Liu C; Huang P; Zhao D; Xia M; Zhong W; Jiang X; Tan M
    Vaccine; 2021 Jan; 39(2):263-271. PubMed ID: 33309483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inclusion of a universal tetanus toxoid CD4(+) T cell epitope P2 significantly enhanced the immunogenicity of recombinant rotavirus ΔVP8* subunit parenteral vaccines.
    Wen X; Wen K; Cao D; Li G; Jones RW; Li J; Szu S; Hoshino Y; Yuan L
    Vaccine; 2014 Jul; 32(35):4420-4427. PubMed ID: 24962749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tandem truncated rotavirus VP8* subunit protein with T cell epitope as non-replicating parenteral vaccine is highly immunogenic.
    Wen X; Cao D; Jones RW; Hoshino Y; Yuan L
    Hum Vaccin Immunother; 2015; 11(10):2483-9. PubMed ID: 26091081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization of Mice by Rotavirus NSP4-VP6 Fusion Protein Elicited Stronger Responses Compared to VP6 Alone.
    Afchangi A; Arashkia A; Shahosseini Z; Jalilvand S; Marashi SM; Roohvand F; Mohajel N; Shoja Z
    Viral Immunol; 2018 Apr; 31(3):233-241. PubMed ID: 29185875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chimeric Hepatitis B core virus-like particles harboring SARS-CoV2 epitope elicit a humoral immune response in mice.
    Sazegari S; Akbarzadeh Niaki M; Afsharifar A; Niazi A; Derakhshandeh A; Moradi Vahdat M; Hemmati F; Eskandari MH
    Microb Cell Fact; 2023 Feb; 22(1):39. PubMed ID: 36841778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parenteral administration of RF 8-2/6/7 rotavirus-like particles in a one-dose regimen induce protective immunity in mice.
    Istrate C; Hinkula J; Charpilienne A; Poncet D; Cohen J; Svensson L; Johansen K
    Vaccine; 2008 Aug; 26(35):4594-601. PubMed ID: 18588935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein.
    Gil MT; de Souza CO; Asensi M; Buesa J
    Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral immunization with live Lactococcus lactis expressing rotavirus VP8 subunit induces specific immune response in mice.
    Marelli B; Perez AR; Banchio C; de Mendoza D; Magni C
    J Virol Methods; 2011 Jul; 175(1):28-37. PubMed ID: 21530589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between Immunogenicity of a Monovalent Parenteral P2-VP8 Subunit Rotavirus Vaccine and Fecal Shedding of Rotavirus following Rotarix Challenge during a Randomized, Double-Blind, Placebo-Controlled Trial.
    Fellows T; Page N; Fix A; Flores J; Cryz S; McNeal M; Iturriza-Gomara M; Groome MJ
    Viruses; 2023 Aug; 15(9):. PubMed ID: 37766217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated molecular and bioprocess engineering for bacterially produced immunogenic modular virus-like particle vaccine displaying 18 kDa rotavirus antigen.
    Tekewe A; Fan Y; Tan E; Middelberg AP; Lua LH
    Biotechnol Bioeng; 2017 Feb; 114(2):397-406. PubMed ID: 27497268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developing an Inactivated Rotavirus Vaccine and Evaluating the Immunogenicity Against a Commercially Available Attenuated Rotavirus Vaccine Using a Mice Animal Model.
    Hashim AS; Aboshanab KM; El-Sayed AF
    Viral Immunol; 2016 Dec; 29(10):565-571. PubMed ID: 27860553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human VP8* mAbs neutralize rotavirus selectively in human intestinal epithelial cells.
    Feng N; Hu L; Ding S; Sanyal M; Zhao B; Sankaran B; Ramani S; McNeal M; Yasukawa LL; Song Y; Prasad BVV; Greenberg HB
    J Clin Invest; 2019 Aug; 129(9):3839-3851. PubMed ID: 31403468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved characteristics and protective efficacy in an animal model of E. coli-derived recombinant double-layered rotavirus virus-like particles.
    Li T; Lin H; Zhang Y; Li M; Wang D; Che Y; Zhu Y; Li S; Zhang J; Ge S; Zhao Q; Xia N
    Vaccine; 2014 Apr; 32(17):1921-31. PubMed ID: 24530406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yeast expression of the VP8* fragment of the rotavirus spike protein and its use as immunogen in mice.
    Andrés I; Rodríguez-Díaz J; Buesa J; Zueco J
    Biotechnol Bioeng; 2006 Jan; 93(1):89-98. PubMed ID: 16193515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequence and phylogenetic analyses of human rotavirus strains: comparison of VP7 and VP8(∗) antigenic epitopes between Tunisian and vaccine strains before national rotavirus vaccine introduction.
    Mouna BH; Hamida-Rebaï MB; Heylen E; Zeller M; Moussa A; Kacem S; Van Ranst M; Matthijnssens J; Trabelsi A
    Infect Genet Evol; 2013 Aug; 18():132-44. PubMed ID: 23684631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles.
    Jiang B; Estes MK; Barone C; Barniak V; O'Neal CM; Ottaiano A; Madore HP; Conner ME
    Vaccine; 1999 Feb; 17(7-8):1005-13. PubMed ID: 10067709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.